U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

2020
742
Substance Class Protein
Created
by admin
on Sat Dec 16 01:03:22 UTC 2023
Edited
by admin
on Sat Dec 16 01:03:22 UTC 2023
Protein Type MONOCLONAL ANTIBODY
Protein Sub Type IGG1
Sequence Origin HUMAN
Sequence Type COMPLETE
Record UNII
Y64GQ0KC0A
Record Status Validated (UNII)
Record Version
  • Download
Related Record Type
Name Type Language
TEPROTUMUMAB
INN   USAN   WHO-DD  
INN   USAN  
Official Name English
RG-1507
Code English
Teprotumumab [WHO-DD]
Common Name English
teprotumumab [INN]
Common Name English
HZN-001
Code English
RG1507
Code English
TEPROTUMUMAB [MI]
Common Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR (CD221)), HUMAN MONOCLONAL IMC-11F8 .GAMMA.1 HEAVY CHAIN (221-215')-DISULFIDE WITH HUMAN MONOCLONAL IMC-11F8 .KAPPA. LIGHT, DIMER (227-227'':230-230'')-BISDISULFIDE
Common Name English
RO-4858696-000
Code English
RO-4858696000
Code English
RO-4858696
Code English
HZN001
Code English
TEPROTUMUMAB [USAN]
Common Name English
RV001 MONOCLONAL
Code English
RO4858696-000
Code English
RO4858696
Code English
RV-001 MONOCLONAL
Code English
R-1507
Code English
IMMUNOGLOBULIN G1, ANTI-(HUMAN INSULIN-LIKE GROWTH FACTOR I RECEPTOR) (HUMAN MONOCLONAL HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL LIGHT CHAIN, DIMER
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C129822
Created by admin on Sat Dec 16 01:03:22 UTC 2023 , Edited by admin on Sat Dec 16 01:03:22 UTC 2023
FDA ORPHAN DRUG 387812
Created by admin on Sat Dec 16 01:03:22 UTC 2023 , Edited by admin on Sat Dec 16 01:03:22 UTC 2023
NCI_THESAURUS C20401
Created by admin on Sat Dec 16 01:03:22 UTC 2023 , Edited by admin on Sat Dec 16 01:03:22 UTC 2023
Code System Code Type Description
RXCUI
2274803
Created by admin on Sat Dec 16 01:03:22 UTC 2023 , Edited by admin on Sat Dec 16 01:03:22 UTC 2023
PRIMARY
MERCK INDEX
m12242
Created by admin on Sat Dec 16 01:03:22 UTC 2023 , Edited by admin on Sat Dec 16 01:03:22 UTC 2023
PRIMARY
CAS
1036734-93-6
Created by admin on Sat Dec 16 01:03:22 UTC 2023 , Edited by admin on Sat Dec 16 01:03:22 UTC 2023
PRIMARY
FDA UNII
Y64GQ0KC0A
Created by admin on Sat Dec 16 01:03:22 UTC 2023 , Edited by admin on Sat Dec 16 01:03:22 UTC 2023
PRIMARY
WIKIPEDIA
TEPROTUMUMAB
Created by admin on Sat Dec 16 01:03:22 UTC 2023 , Edited by admin on Sat Dec 16 01:03:22 UTC 2023
PRIMARY
EVMPD
SUB178558
Created by admin on Sat Dec 16 01:03:22 UTC 2023 , Edited by admin on Sat Dec 16 01:03:22 UTC 2023
PRIMARY
CAS
1422662-75-6
Created by admin on Sat Dec 16 01:03:22 UTC 2023 , Edited by admin on Sat Dec 16 01:03:22 UTC 2023
NO STRUCTURE GIVEN
USAN
XX-19
Created by admin on Sat Dec 16 01:03:22 UTC 2023 , Edited by admin on Sat Dec 16 01:03:22 UTC 2023
PRIMARY
DRUG CENTRAL
5387
Created by admin on Sat Dec 16 01:03:22 UTC 2023 , Edited by admin on Sat Dec 16 01:03:22 UTC 2023
PRIMARY
DAILYMED
Y64GQ0KC0A
Created by admin on Sat Dec 16 01:03:22 UTC 2023 , Edited by admin on Sat Dec 16 01:03:22 UTC 2023
PRIMARY
NCI_THESAURUS
C95797
Created by admin on Sat Dec 16 01:03:22 UTC 2023 , Edited by admin on Sat Dec 16 01:03:22 UTC 2023
PRIMARY
RXCUI
2274802
Created by admin on Sat Dec 16 01:03:22 UTC 2023 , Edited by admin on Sat Dec 16 01:03:22 UTC 2023
ALTERNATIVE
ChEMBL
CHEMBL1743079
Created by admin on Sat Dec 16 01:03:22 UTC 2023 , Edited by admin on Sat Dec 16 01:03:22 UTC 2023
PRIMARY
DRUG BANK
DB06343
Created by admin on Sat Dec 16 01:03:22 UTC 2023 , Edited by admin on Sat Dec 16 01:03:22 UTC 2023
PRIMARY
INN
9107
Created by admin on Sat Dec 16 01:03:22 UTC 2023 , Edited by admin on Sat Dec 16 01:03:22 UTC 2023
PRIMARY
ECHA (EC/EINECS)
289-554-4
Created by admin on Sat Dec 16 01:03:22 UTC 2023 , Edited by admin on Sat Dec 16 01:03:22 UTC 2023
PRIMARY
From To
1_22 1_96
1_145 1_201
1_221 3_215
1_227 2_227
1_230 2_230
1_262 1_322
1_368 1_426
2_22 2_96
2_145 2_201
2_221 4_215
2_262 2_322
2_368 2_426
3_23 3_88
3_135 3_195
4_23 4_88
4_135 4_195
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_298
N 2_298
Related Record Type Details
INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR
TARGET -> INHIBITOR
TEPROTUMUMAB-TRBW
SUB_CONCEPT->SUBSTANCE
Related Record Type Details
TEPROTUMUMAB
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
MOL_WEIGHT:ESTIMATE CHEMICAL
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966